INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?Zacks Investment Research · 1 day ago
Inspire Medical Systems Inc (INSP) Stock Up 3.3% and Still Undervalued -- GF Score: 64/100GuruFocus · Oct 9, 2026
Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRCGuruFocus · Oct 7, 2026
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026GlobeNewsWire · Oct 5, 2026
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve StimulationZacks Investment Research · Oct 5, 2026
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial PanelGlobeNewsWire · Oct 1, 2026Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 3, 2026 | -$0.24 | $0.14 | Beat |
| May 4, 2026 | -$0.28 | $0.10 | Beat |
| Feb 11, 2026 | $0.69 | $1.65 | Beat |
| Nov 3, 2025 | -$0.15 | $0.38 | Beat |
| Aug 4, 2025 | $0.22 | $0.45 | Beat |
| May 5, 2025 | -$0.23 | $0.10 | Beat |